Mobile Individual Atrial Fibrillation Management Program

Brief summary (registry, in English)

The aim of the study is to develop a mobile individual atrial fibrillation management (m-BAFY) program and to evaluate the effects of the program on symptom severity, medication compliance, self-care agency and quality of life. The main questions that the study aims to answer are as follows; * Is the m-BAFY program effective in symptom control? * Is the m-BAFY program effective in increasing medication compliance? * Is the m-BAFY program effective in improving self-care agency? * Is the m-BAFY program effective in improving quality of life? In order to measure whether m-BAFY is effective, the researchers will download this application to one group's phones, and the other group will not download the application. Participants; * Use this application for 3 months * Patients in the intervention group use the application at least once every two weeks. * Fill in the symptom diary in the application. * Clinical interviews are called for the first interview, at the end of the 1st month and at the end of the 3rd month.

What you commit to

• Study type: Interventional
• Participants enrolled: 90
• From 10 Jun 2024 to the primary completion date, 15 Jan 2025
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.